Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
Saved in:
| Title: | Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting. |
|---|---|
| Authors: | Deschanvres, Colin1 (AUTHOR) colin.deschanvres@chu-nantes.fr, Reynes, Jacques2,3 (AUTHOR), Lamaury, Isabelle4 (AUTHOR), Rey, David5 (AUTHOR), Palich, Romain6 (AUTHOR), Bani-Sadr, Firouzé7 (AUTHOR), Robineau, Olivier8 (AUTHOR), Duvivier, Claudine9 (AUTHOR), Hocqueloux, Laurent10 (AUTHOR), Cuzin, Lise11,12 (AUTHOR), Joly, Veronique13 (AUTHOR), Raffi, Francois1 (AUTHOR), Cabie, André12 (AUTHOR), Allavena, Clotilde1 (AUTHOR), Group, the Dat'AIDS Study (AUTHOR), Dat’AIDS Study Group (CORPORATE AUTHOR) |
| Source: | Journal of Antimicrobial Chemotherapy (JAC). Jan2022, Vol. 77 Issue 1, p196-204. 9p. |
| Database: | Environment Complete |
| ISSN: | 03057453 |
|---|---|
| DOI: | 10.1093/jac/dkab367 |
